FrancophonIA/ELRC3.0 huggingface dataset:
English: Patients should be asked to continue treatment but to seek medical advice if asthma symptoms remain uncontrolled or worsen after initiation of treatment with Revinty Ellipta.
Croatian: Bolesnike treba uputiti da nastave liječenje, ali i da zatraže liječnički savjet ako se simptomi astme i dalje ne mogu kontrolirati ili se pogoršaju nakon početka terapije lijekom Revinty Ellipta.
English: If you accidentally take more Revinty Ellipta than your doctor has instructed, talk to your doctor or pharmacist.
Croatian: Ako slučajno primijenite više lijeka Revinty Ellipta nego što Vam je liječnik rekao, obratite se svom liječniku ili ljekarniku.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 02 May 2014
Croatian: Datum prvog odobrenja: 02. svibnja 2014.
English: Patients with asthma should be given the strength of Revinty Ellipta containing the appropriate fluticasone furoate (FF) dosage for the severity of their disease.
Croatian: Bolesnicima s astmom treba propisati onu jačinu lijeka Revinty Ellipta koja sadrži odgovarajuću dozu flutikazonfuroata (FF) za njihovu težinu bolesti.
English: This is because larger doses of Revinty Ellipta may reduce the amount of steroid hormones produced naturally by your body.
Croatian: Ellipta mogu smanjiti količinu steroidnih hormona koje Vaše tijelo prirodno stvara.
English: If you have any of the following symptoms after taking Revinty Ellipta stop taking this medicine and tell your doctor immediately.
Croatian: Ako imate bilo koji od sljedećih simptoma nakon primjene lijeka Revinty Ellipta prekinite primjenu ovog lijeka i odmah obavijestite svog liječnika.
English: - The other ingredients are lactose monohydrate (See section 2) and magnesium stearate.
Croatian: Drugi sastojci su laktoza hidrat (pogledajte dio 2.) i magnezijev stearat.
English: You do not need to prepare Revinty Ellipta in any special way, not even the first time you use it.
Croatian: Lijek Revinty Ellipta ne morate posebno pripremati za primjenu, čak ni kada ga koristite prvi puta.
English: If you use more Revinty Ellipta than you should
Croatian: Ako primijenite više lijeka Revinty Ellipta nego što ste trebali
English: Other medicines and Revinty Ellipta
Croatian: Drugi lijekovi i Revinty Ellipta
English: If you have been told by your doctor that you have an intolerance to some sugars, or to milk protein, contact to your doctor before using this medicine.
Croatian: Ako Vam je liječnik rekao da ne podnosite neke šećere ili mliječne proteine, obratite se liječniku prije nego što primijenite ovaj lijek.
English: Corticosteroids have been shown to have a wide range of actions on multiple cell types (e.g. eosinophils, macrophages, lymphocytes) and mediators (e.g. cytokines and chemokines involved in inflammation).
Croatian: Pokazalo se da kortikosteroidi imaju širok spektar djelovanja na više tipova stanica (npr. na eozinofile, makrofage, limfocite) i posrednika (npr. na citokine i kemokine koji sudjeluju u upali).
English: If you have moderate or severe liver disease, your doctor will limit your dose to the lower strength of Revinty Ellipta (92/22 micrograms once daily).
Croatian: Ako imate umjerenu ili tešku jetrenu bolest, Vaš liječnik će ograničiti dozu lijeka Revinty Ellipta na manju jačinu (92/22 mikrograma jedanput na dan).
English: There is no relevant use of Revinty Ellipta in the paediatric population for the indication of COPD.
Croatian: Nije opravdana primjena lijeka Revinty Ellipta u pedijatrijskoj populaciji za indikaciju KOPB-a.
English: What Revinty Ellipta looks like and contents of the pack The Ellipta device itself is a light grey inhaler with a yellow mouthpiece cover and a dose counter.
Croatian: Kako Revinty Ellipta izgleda i sadržaj pakiranja Sam uređaj Ellipta je svijetlosivi inhalator sa žutim poklopcem nastavka za usta i brojačem doza.
English: Rinsing your mouth out with water immediately after using Revinty Ellipta may help stop this side effect developing.
Croatian: Ispiranje usta vodom odmah nakon primjene lijeka Revinty Ellipta može pomoći u sprječavanju pojave ove nuspojave.
English: Revinty Ellipta contains lactose
Croatian: Revinty Ellipta sadrži laktozu
English: Revinty Ellipta contains two active substances: fluticasone furoate and vilanterol.
Croatian: Revinty Ellipta sadrži dvije djelatne tvari: flutikazonfuroat i vilanterol.
English: If patients are inadequately controlled on Revinty Ellipta 92/22 micrograms, the dose can be increased to 184/22 micrograms, which may provide additional improvement in asthma control.
Croatian: Ako bolesnici nisu dobro kontrolirani lijekom Revinty Ellipta od 92/22 mikrograma, doza se može povećati na 184/22 mikrograma, što može dodatno poboljšati kontrolu astme.
English: The desiccant sachet should be thrown away and it should not be opened, eaten or inhaled.
Croatian: Vrećicu sa sredstvom za sušenje treba baciti, ne smije se otvoriti, jesti ili inhalirati.
English: The European Medicines Agency has deferred the obligation to submit the results of studies with Revinty Ellipta in one or more subsets of the paediatric population in asthma (see section 4.2 for information on paediatric use).
Croatian: Europska agencija za lijekove odgodila je obvezu podnošenja rezultata ispitivanja lijeka Revinty Ellipta u jednoj ili više podskupina pedijatrijske populacije u astmi (vidjeti dio 4.2 za informacije o pedijatrijskoj primjeni).
English: Pharmacotherapeutic group: Drugs for obstructive airways diseases, adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics, ATC code: R03AK10.
Croatian: Farmakoterapijska skupina: Lijekovi za liječenje opstruktivnih bolesti dišnih puteva, adrenergici u kombinaciji s kortikosteroidima ili drugim lijekovima, osim antikolinergika, ATK oznaka: R03AK10.
English: Revinty Ellipta is indicated for the symptomatic treatment of adults with COPD with a FEV1<70% predicted normal (post-bronchodilator) with an exacerbation history despite regular bronchodilator therapy.
Croatian: Revinty Ellipta je indiciran za simptomatsko liječenje odraslih bolesnika s KOPB-om koji imaju FEV1 < 70% predviđene normalne vrijednosti (nakon primjene bronhodilatatora) i s egzacerbacijama bolesti unatoč redovitom liječenju bronhodilatatorima.
English: The safety and efficacy of Revinty Ellipta in children under 12 years of age has not yet been established in the indication for asthma.
Croatian: Sigurnost i djelotvornost lijeka Revinty Ellipta u indikaciji astme u djece mlađe od 12 godina nisu još ustanovljene.
English: Revinty Ellipta should not be used in conjunction with other long-acting beta2-adrenergic agonists or medicinal products containing longacting beta2-adrenergic agonists.
Croatian: Revinty Ellipta se ne smije koristiti u kombinaciji s drugim dugodjelujućim agonistima beta2-adrenergičkih receptora niti lijekovima koji sadrže dugodjelujuće beta2-adrenergičke agoniste.
English: Patients usually experience an improvement in lung function within 16-17 minutes of inhaling Revinty Ellipta.
Croatian: Bolesnici obično osjete poboljšanje plućne funkcije unutar 16-17 minuta nakon inhaliranja lijeka Revinty Ellipta.
English: Use Revinty Ellipta at the same time each day as it is effective over 24 hours It is very important that you use this medicine every day, as instructed by your doctor.
Croatian: Primjenjujte Revinty Ellipta svakoga dana u isto vrijeme jer je on učinkovit tijekom 24 sata
English: The European Medicines Agency has waived the obligation to submit the results of studies with Revinty Ellipta in all subsets of the paediatric population in COPD (see section 4.2 for information on paediatric use).
Croatian: Europska agencija za lijekove izuzela je obvezu podnošenja rezultata ispitivanja lijeka Revinty Ellipta u svim podskupinama pedijatrijske populacije u KOPB-u (vidjeti dio 4.2 za informacije o pedijatrijskoj primjeni).
English: What you need to know before you use Revinty Ellipta
Croatian: Što morate znati prije nego počnete primjenjivati Revinty Ellipta
English: Immediate breathing difficulties after using Revinty Ellipta are rare.
Croatian: Tegobe s disanjem neposredno nakon primjene lijeka Tegobe s disanjem neposredno nakon primjene lijeka Revinty Ellipta su rijetke.
English: In two replicate 12 month studies in a total of 3,255 patients with COPD the incidence of bone fractures overall was low in all treatment groups, with a higher incidence in all Revinty Ellipta groups (2%) compared with the vilanterol 22 micrograms group (<1%).
Croatian: U dva 12-mjesečna replikacijska ispitivanja u kojima je sudjelovalo ukupno 3255 bolesnika s KOPB-om, ukupna incidencija fraktura kostiju bila je niska u svim liječenim skupinama, s time da je incidencija bila viša u svim skupinama u kojima su bolesnici primali Revinty Ellipta (2%) nego u skupinama koje su primale vilanterol od 22 mikrograma (<1%).
English: In peripheral blood mononuclear cells from subjects with COPD, a larger anti-inflammatory effect was seen in the presence of the combination of fluticasone furoate/vilanterol compared with fluticasone furoate alone at concentrations achieved with clinical doses.
Croatian: U mononuklearnim stanicama periferne krvi ispitanika s KOPB-om primijećen je jači protuupalni učinak u prisutnosti kombinacije flutikazonfuroat/vilanterol u usporedbi s prisutnošću samo flutikazonfuroata pri koncentracijama koje se postižu primjenom kliničkh doza.
English: If your symptoms (breathlessness, wheezing, cough) do not improve or get worse, or if you are using your quick-acting inhaler more often contact your doctor as soon as possible.
Croatian: Ako Vam se simptomi (nedostatak zraka, piskanje pri disanju, kašalj) ne poboljšaju ili se pogoršaju, ili primjenjujete brzodjelujući inhalacijski lijek češće nego inače,
English: Although there were more fractures in the Revinty Ellipta groups compared with the vilanterol 22 micrograms group, fractures typically associated with corticosteroid use (e.g., spinal compression/thoracolumbar vertebral fractures, hip and acetabular fractures) occurred in <1% of the Revinty Ellipta and vilanterol treatment arms.
Croatian: Premda je u skupinama koje su primale Revinty Ellipta fraktura bilo više nego u skupinama koje su primale vilanterol od 22 mikrograma, frakture koje se u pravilu povezuju s primjenom kortikosteroida (npr. kompresivni prijelomi torako-lumbalnih kralježaka, frakture kuka i zglobne čašice) zabilježene su u <1% ispitanika i u skupinama koje su primale Revinty Ellipta i u onima koje su primale vilanterol.
English: *, ** See below ‘Description of selected adverse reactions' *Pneumonia (see section 4.4)
Croatian: Opis odabranih nuspojava *Pneumonija (vidjeti dio 4.4)
English: Revinty Ellipta has been shown to reduce flare-ups and symptoms of asthma.
Croatian: Pokazalo se da Revinty Ellipta smanjuje razbuktavanje i simptome astme.
English: The higher strength of Revinty Ellipta (184 micrograms fluticasone furoate and 22 micrograms of vilanterol) is not suitable for the treatment of COPD.
Croatian: Jača doza lijeka Revinty Ellipta (184 mikrograma flutikazonfuroata i 22 mikrograma vilanterola) nije prikladna za liječenje KOPB-a.
English: Asthma Revinty Ellipta is indicated for the regular treatment of asthma in adults and adolescents aged 12 years and older where use of a combination medicinal product (long-acting beta2-agonist and inhaled corticosteroid) is appropriate:
Croatian: Revinty Ellipta je indiciran za redovito liječenje astme u odraslih osoba i adolescenata u dobi od 12 i više godina kod kojih je primjerena primjena kombiniranog lijeka (dugodjelujućeg beta2-agonista i inhalacijskog kortikosteroida) :
English: Revinty Ellipta should be discontinued immediately, the patient assessed and alternative therapy instituted if necessary.
Croatian: Treba odmah prekinuti terapiju lijekom Revinty Ellipta, pregledati bolesnika te po potrebi uvesti drugu terapiju.
English: Revinty Ellipta has been shown to reduce flare-ups of COPD symptoms.
Croatian: Pokazalo se da Revinty Ellipta smanjuje razbuktavanje simptoma KOPB-a.
English: A starting dose of one inhalation of Revinty Ellipta 92/22 micrograms once daily should be considered for adults and adolescents 12 years and over who require a low to mid dose of inhaled corticosteroid in combination with a long-acting beta2-agonist.
Croatian: Početnu dozu od jedne inhalacije lijeka Revinty Ellipta od 92/22 mikrograma jedanput na dan treba razmotriti za odrasle osobe i adolescente u dobi od 12 i više godina kojima je potrebna mala do srednja doza inhalacijskog kortikosteroida u kombinaciji s dugodjelujućim beta2-agonistom.
English: All patients were required to have a smoking history of at least 10 pack years; a post-salbutamol FEV1/FVC ratio less than or equal to 0.70; post-salbutamol FEV1 less than or equal to 70% predicted and have a Modified Medical Research Council (mMRC) dyspnea score 2 (scale 0-4) at screening.
Croatian: Svi su bolesnici morali biti pušači sa stažem od najmanje 10 kutija-godina; imati omjer FEV1/FVC nakon uzimanja salbutamola od najviše 0,70; FEV1 nakon uzimanja salbutamola od najviše 70% predviđene vrijednosti te rezultat dispneje ≥2 (na ljestvici od 0-4) prema modificiranoj MRC ljestvici pri probiru.
English: The primary endpoint was all-cause mortality and a secondary endpoint was a composite of cardiovascular events (on-treatment cardiovascular death, myocardial infarction, stroke, unstable angina, or transient ischemic attack).
Croatian: dok su sekundarnu mjeru ishoda činili objedinjeni kardiovaskularni događaji (smrt tijekom liječenja zbog kardiovaskularnog uzroka, infarkt miokarda, moždani udar, nestabilna angina ili tranzitorna ishemijska ataka).
English: If your breathing or wheezing gets worse straight after using Revinty Ellipta, stop using it and get medical help immediately.
Croatian: Ako Vam se disanje ili piskanje pri disanju pogoršaju neposredno nakon primjene lijeka Revinty Ellipta, odmah ga prestanite primjenjivati i zatražite liječničku pomoć.
English: INFORMATION IN BRAILLE revinty ellipta 92:22
Croatian: 16. PODACI NA BRAILLEOVOM PISMU revinty ellipta 92:22
English: Revinty Ellipta 184/22 micrograms should be considered for adults and adolescents 12 years and over who require a higher dose of inhaled corticosteroid in combination with a long-acting beta2-agonist.
Croatian: Primjenu lijeka Revinty Ellipta od 184/22 mikrograma treba razmotriti za odrasle osobe i adolescente u dobi od 12 i više godina kojima je potrebna veća doza inhalacijskog kortikosteroida u kombinaciji s dugodjelujućim beta2-agonistom.
English: The maximum recommended dose is Revinty Ellipta 184/22 micrograms once daily.
Croatian: Najveća preporučena doza lijeka Revinty Ellipta je 184/22 mikrograma jedanput na dan.
English: Patients usually experience an improvement in lung function within 15 minutes of inhaling Revinty Ellipta.
Croatian: Bolesnici obično osjete poboljšanje plućne funkcije unutar 15 minuta nakon inhaliranja lijeka Revinty Ellipta.
English: One inhalation of Revinty Ellipta 92/22 micrograms once daily.
Croatian: Jedna inhalacija lijeka Revinty Ellipta 92/22 mikrograma jedanput na dan.
English: INFORMATION IN BRAILLE revinty ellipta 184:22
Croatian: 16. PODACI NA BRAILLEOVOM PISMU revinty ellipta 184:22
English: If you forget to use Revinty Ellipta Do not take a double dose to make up for a forgotten dose.
Croatian: Nemojte primijeniti dvostruku dozu kako biste nadoknadili zaboravljenu dozu.
English: • Slide the cover upwards as far as it will go, to cover the mouthpiece.
Croatian: • Povucite poklopac prema gore koliko ide kako biste prekrili nastavak za usta.
English: Rare side effects These may affect up to 1 in 1,000 people:
Croatian: Rijetke nuspojave Mogu se javiti u do 1 na 1000 osoba
English: Revinty Ellipta 184/22 micrograms is not indicated for patients with COPD.
Croatian: Revinty Ellipta 184/22 mikrograma nije indiciran za liječenje bolesnika s KOPB-om.
English: BIAL, Portela & Ca. SA. Tel: + 351 22 986 61 00 info@bial.com
Croatian: SA. Tel: + 351 22 986 61 00 info@bial.com
English: Cardiovascular effects, such as cardiac arrhythmias e.g. supraventricular tachycardia and extrasystoles may be seen with sympathomimetic medicinal products including Revinty Ellipta.
Croatian: Simpatomimetici, uključujući Revinty Ellipta, mogu izazvati kardiovaskularne učinke kao što su srčane aritmije, npr. supraventrikularna tahikardija i ekstrasistole.
English: A repeat dose CYP3A4 drug interaction study was performed in healthy subjects with the fluticasone furoate/vilanterol combination (184/22 micrograms) and the strong CYP3A4 inhibitor ketoconazole (400mg).
Croatian: . U zdravih je ispitanika provedeno ispitivanje interakcije s inhibitorom CYP3A4 uz primjenu ponovljenih doza, u kojem je kombinacija flutikazonfuroat/vilanterol (184/22 mikrograma) primijenjena sa snažnim inhibitorom CYP3A4 ketokonazolom (400 mg).
English: If you are breast-feeding, check with your doctor before you use Revinty Ellipta.
Croatian: Ako dojite, obratite se svom liječniku prije nego primijenite Revinty Ellipta.
English: • patients already adequately controlled on both inhaled corticosteroid and long-acting beta2-agonist.
Croatian: • u bolesnika adekvatno kontroliranih inhalacijskim kortikosteroidima i dugodjelujućim inhalacijskim beta2-agonistima
English: Revinty Ellipta should not be used to relieve a sudden attack of breathlessness or wheezing.
Croatian: Revinty Ellipta se ne smije primjenjivati za ublažavanje simptoma u slučaju naglog napadaja s nedostatkom zraka ili piskanjem pri disanju.
English: If you are breast-feeding, you must check with your doctor before you use Revinty Ellipta.
Croatian: Ako dojite, morate se obratiti svom liječniku prije nego primijenite Revinty Ellipta.
English: Do not use Revinty Ellipta if you are allergic to fluticasone furoate, vilanterol or any other ingredients of this medicine (listed in section 6).
Croatian: Nemojte primjenjivati Revinty Ellipta ako ste alergični na flutikazonfuroat, vilanterol ili neki drugi sastojak ovog lijeka (naveden u dijelu 6.) ako mislite da se gore navedeno odnosi na Vas, nemojte primjenjivati Revinty Ellipta dok se ne posavjetujete sa svojim liječnikom.
English: - Contact your doctor if you experience increased thirst, frequent urination or unexplained tiredness
Croatian: obratite se svom liječniku ako primijetite povećanu žed, učestalo mokrenje ili neobjašnjiv umor (znakovi visoke razine šećera u krvi).
English: Revinty Ellipta is for inhalation use.
Croatian: Revinty Ellipta namijenjen je za inhaliranje.
English: Uncommon side effects This may affect up to 1 in 100 people:
Croatian: Manje česte nuspojave Mogu se javiti u do 1 na 100 osoba:
English: if you have ever been told you have diabetes or high blood sugar.
Croatian: ako imate tuberkulozu (TB) pluća ili dugotrajne ili neliječene infekcije. ako Vam je ikada rečeno da imate šećernu bolest ili visoku razinu šećera u krvi.
English: Your Revinty Ellipta inhaler carton contains
Croatian: Vaša kutija s Revinty Ellipta inhalatorom sadrži
English: How to use Revinty Ellipta See ‘Step-by-step instructions' after section 6 of this leaflet for full information.
Croatian: Za više informacija pročitajte ''Upute za primjenu korak po korak'' nakon dijela 6. ove upute.
English: What Revinty Ellipta contains - The active substances are fluticasone furoate and vilanterol.
Croatian: Sadržaj pakiranja i druge informacije Što Revinty Ellipta sadrži - Djelatne tvari su flutikazonfuroat i vilanterol.
English: Two different strengths of Revinty Ellipta are available: fluticasone furoate 92 micrograms/vilanterol 22 micrograms and fluticasone furoate 184 micrograms/vilanterol 22 micrograms.
Croatian: Dostupne su dvije različite doze lijeka Revinty Ellipta: flutikazonfuroat od 92 mikrograma/vilanterol od 22 mikrograma i flutikazonfuroat od 184 mikrograma/vilanterol od 22 mikrograma.
English: Revinty Ellipta is for inhalation use only.
Croatian: Revinty Ellipta namijenjen je isključivo za inhaliranje.
English: • tremor • anxiety
Croatian: • tremor
English: A randomised, double-blind, parallel group, 24 week study (201378) was conducted to demonstrate noninferiority (using a margin of -100 mL for trough FEV1) of fluticasone furoate/vilanterol 92/22 once daily to salmeterol/FP 50/250 twice daily in adults and adolescents whose asthma was well controlled following 4 weeks of treatment with open-label salmeterol/FP 50/250 twice daily (N=1504).
Croatian: flutikazonfuroata/vilanterola 92/22 jedanput na dan i salmeterola/flutikazonpropionata 50/250 dvaput na dan u odraslih i adolescenata s dobro kontroliranom astmom nakon 4 tjedna otvorenog primanja salmeterola/flutikazonpropionata 50/250 dvaput na dan (N=1504).
English: How to use Revinty Ellipta
Croatian: Kako primjenjivati Revinty Ellipta
English: EU/1/14/929/004 EU/1/14/929/005
Croatian: EU/1/14/929/004 EU/1/14/929/005 EU/1/14/929/006
English: How to store Revinty Ellipta
Croatian: Kako čuvati Revinty Ellipta
English: - Contact your doctor if you experience blurred vision or other visual disturbances.
Croatian: Tijekom liječenja lijekom Revinty Ellipta obratite se svom liječniku ukoliko primijetite da Vam je vid zamućen ili ako primijetite druge poremećaje vida.
English: 0.19 in the FF 92 micrograms group (approximately 1 in every 5 years) and 0.14 in the fluticasone furoate/vilanterol 92/22 micrograms group (approximately 1 in every 7 years).
Croatian: Stopa teških egzacerbacija astme po bolesniku po godini iznosila je 0,19 u skupini koja je primala flutikazonfuroat od 92 mikrograma (približno 1 svakih 5 godina) i 0,14 u skupini koja je primala flutikazonfuroat/vilanterol od 92/22 mikrograma (približno 1 svakih 7 godina).
English: Talk to your doctor before you use Revinty Ellipta: if you have liver disease, as you may be more likely to have side effects.
Croatian: Obavijestite svog liječnika ako se pri primjeni lijeka Revinty Ellipta pojavi bilo koja od sljedećih nuspojava - može se raditi o simptomima infekcije pluća:
English: NAME OF THE MEDICINAL PRODUCT Revinty Ellipta 92 micrograms/22 micrograms inhalation powder, pre-dispensed
Croatian: NAZIV LIJEKA Revinty Ellipta 92 mikrograma/22 mikrograma prašak inhalata, dozirani
English: NAME OF THE MEDICINAL PRODUCT Revinty Ellipta 184 micrograms/22 micrograms inhalation powder, pre-dispensed
Croatian: NAZIV LIJEKA Revinty Ellipta 184 mikrograma/22 mikrograma prašak inhalata, dozirani
English: • swelling, sometimes of the face or mouth (angioedema)
Croatian: - kožni osip (koprivnjača) ili crvenilo - oticanje, katkada lica ili usta (angioedem) - piskanje pri disanju, kašalj ili otežano disanje
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (SINGLE PACK) 184/22 micrograms
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU KUTIJA (POJEDINAČNO PAKIRANJE) 184/22 mikrograma
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Revinty Ellipta 92 micrograms/22 micrograms inhalation powder fluticasone furoate/vilanterol
Croatian: NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA Revinty Ellipta 92 mikrograma/22 mikrograma prašak inhalata flutikazonfuroat/vilanterol
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Revinty Ellipta 184 micrograms/22 micrograms inhalation powder fluticasone furoate/vilanterol
Croatian: NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA Revinty Ellipta 184 mikrograma/22 mikrograma prašak inhalata flutikazonfuroat/vilanterol
English: While you're using Revinty Ellipta
Croatian: Ako ste zaboravili primijeniti Revinty Ellipta
English: MARKETING AUTHORISATION HOLDER GlaxoSmithKline (Ireland) Limited 12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland
Croatian: 12 Riverwalk, Citywest Business Campus, Dublin 24, Irska
English: Magyarország GlaxoSmithKline Kft. Tel.: + 36 1 225 5300
Croatian: GlaxoSmithKline Malta Tel: + 356 21 238131
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING BUNDLE LABEL (WITH BLUE BOX- MULTIPACK) 92/22 micrograms
Croatian: NALJEPNICA NA OMOTU (S PLAVIM OKVIROM - VIŠESTRUKO PAKIRANJE) 92/22 mikrograma